Daim ntawv tshaj tawm #WHO tus kab mob ntsws tshiab tshaj tawm qhia qhov tseeb: 8.2 lab tus neeg mob TB tshiab tau kuaj pom hauv xyoo 2023 - qhov siab tshaj plaws txij li kev soj ntsuam thoob ntiaj teb tau pib xyoo 1995. Qhov kev nce ntawm 7.5 lab hauv 2022 rov ua dua TB raws li qhovua tus kab mob killer, tshaj COVID-19.
Txawm li cas los xij, ib qho teeb meem loj dua ua rau qhov kev rov tshwm sim dua:Antimicrobial Resistance (AMR). LEEJ TWG ua haujlwm uas los ntawm 2050, AMR tuaj yeem thovtxog li 10 lab lub neej txhua xyoothoob ntiaj teb, nrog cov tshuaj tiv thaiv kab mob TB (DR-TB) yog tus tsav tsheb tseem ceeb. Hauv 2019 ib leeg, AMR ncaj qha tua 1.3 lab tus tib neeg -tshaj HIV/AIDS thiab malaria ua ke-Thiab yog tam sim nothib peb ua rau tuag thoob ntiaj teb. Yog tias tsis muaj kev cuam tshuam, kev tuag los ntawm AMR tuaj yeem ncav cuag39 lab los ntawm 2050, nrog kev poob nyiaj txiag topping$100 trillion.
Vim li cas Kev Ntsuas Sijhawm Tsis Muaj Kev Sib Tham
Kev kho tus kab mob TB cuam tshuam rau kev tshawb pom ntxov thiab kho cov tshuaj kho kom raug. Txawm li cas los xij, kev siv tshuaj tua kab mob tsis raug cai tau ua kom muaj ntau yam tshuaj tiv thaiv kab mob TB (MDR-TB), hloov cov kab mob uas kho tau rau hauv kev hem thawj tuag. Alarmingly:
Cov tshuaj tiv thaiv kab mob TB suav rau 1/3 ntawm AMR tuag thoob ntiaj teb.
Cov neeg laus ntsib kev nce AMR kev tuag(nce 80% txij li xyoo 1990 ntawm cov neeg laus).
Kev hloov huab cua tuaj yeemUa phem rau AMR kis los ntawm 2.4% los ntawm 2050, disproportionately cuam tshuam cov cheeb tsam uas tau nyiaj tsawg.
LEEJ TWG hu xov tooj sai rau kev tsim kho tshiab hauv kev kuaj mob sai los tiv thaiv kev siv tsis raug thiab kaw qhov sib txawv
Macro & Micro-Test's CE-Certified Triple TB Kit: Cov cuab yeej Precision rau AMR Era
Peb cov kev daws teeb meem ua raws li WHO's AMR kev tswj hwm lub tswv yim los ntawm kev ua haujlwmIb txhij kuaj pom tus kab mob TB + rifampicin (RIF) + isoniazid (INH) tsis kam-Qhov tseem ceeb rau kev txwv DR-TB.
Cov yam ntxwv tseem ceeb:
Ceev & raug: Cov txiaj ntsig hauv 2-2.5 teev nrog kev txhais lus tsis siv neeg (yuav tsum tau kawm tsawg kawg).
Cov Hom PhiajTB: IS6110 gene
RIF tsis kam: rpoB (507 ~ 533)
INH-resistance: InhA, AhpC, katG 315
Siab rhiab heev: Pom tsawg li 10 kab mob / mL (TB) thiab 150-200 kab mob / mL rau cov cim tiv thaiv.
WHO-Ua raws: Ua tau raws li cov lus qhia rau kev tswj DR-TB.
Broad Compatibility: Ua haujlwm nrog PCR loj (xws li Bio-Rad CFX96, SLAN-96P/S).
Vim Li Cas Qhov Tseem Ceeb:
Kev txheeb xyuas ceev ceev ntawm cov noob tiv thaiv tiv thaiv kev siv tshuaj tua kab mob tsis zoo, txo kev sib kis,
Hu rau Action
Lub convergence ntawm TB resurgence thiab AMR xav tau cov cuab yeej uas yuav ceev nrog precision. Peb cov khoom siv txuas rau qhov sib txawv no—kom kev kho mob pib yog, thawj zaug.
Kawm ntxiv:
https://www.mmtest.com/mycobacterium-tuberculosis-nucleic-acid-and-rifampicin%ef%bc%8cisoniazid-resistance-product/
Hu rau:marketing@mmtest.com
#IVD #PCR #AMRCrisis #DrugResistance #TB #ENDTB #MDRTB #Diagnostics #GlobalHealth #WHO #MacroMicroTest
Post lub sij hawm: Nov-25-2025